- Home
- AWX vs IMRN Comparison
AWX vs IMRN Comparison
Compare AWX & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- IMRN
- Stock Information
- Founded
- AWX 1998
- IMRN 1994
- Country
- AWX United States
- IMRN Australia
- Employees
- AWX N/A
- IMRN N/A
- Industry
- AWX Environmental Services
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AWX Utilities
- IMRN Health Care
- Exchange
- AWX Nasdaq
- IMRN Nasdaq
- Market Cap
- AWX 9.7M
- IMRN 9.2M
- IPO Year
- AWX 1998
- IMRN N/A
- Fundamental
- Price
- AWX $2.51
- IMRN $1.66
- Analyst Decision
- AWX
- IMRN Strong Buy
- Analyst Count
- AWX 0
- IMRN 1
- Target Price
- AWX N/A
- IMRN $5.00
- AVG Volume (30 Days)
- AWX 5.2K
- IMRN 668.0K
- Earning Date
- AWX 08-08-2025
- IMRN 09-08-2025
- Dividend Yield
- AWX N/A
- IMRN N/A
- EPS Growth
- AWX 686.28
- IMRN N/A
- EPS
- AWX 0.03
- IMRN N/A
- Revenue
- AWX $78,200,000.00
- IMRN $4,048,286.00
- Revenue This Year
- AWX N/A
- IMRN N/A
- Revenue Next Year
- AWX N/A
- IMRN N/A
- P/E Ratio
- AWX $82.96
- IMRN N/A
- Revenue Growth
- AWX N/A
- IMRN 82.90
- 52 Week Low
- AWX $2.10
- IMRN $1.50
- 52 Week High
- AWX $3.99
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- AWX 43.59
- IMRN 45.16
- Support Level
- AWX $2.51
- IMRN $1.57
- Resistance Level
- AWX $2.65
- IMRN $1.71
- Average True Range (ATR)
- AWX 0.04
- IMRN 0.08
- MACD
- AWX -0.01
- IMRN -0.00
- Stochastic Oscillator
- AWX 0.26
- IMRN 39.13
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.